This site is intended for Healthcare professionals only.
×

ICMR Issues guidelines on Type 2 Diabetes, Invites Comments; Check out details


ICMR Issues guidelines on Type 2 Diabetes, Invites Comments; Check out details

You can send your Suggestions/Comments to Dr. Tanvir Kaur, Scientist ‘F’ at doctanvirkaur@gmail.com   by 18th May 2018; 5pm (IST)

New Delhi: On its way to prepare the Standard Treatment Protocol to strengthen physicians in battling the growing menace of Type 2 Diabetes in the country, Indian Council of Medical Research has released Draft Guidelines on issue. ICMR has also invited comments/suggestions on the same

The draft guidelines titled “Guidelines for Management of Type 2 Diabetes  “ note that India today has the second largest number of people with diabetes in the world. The International Diabetes Federation (IDF) estimates that there are 72.9 million people with diabetes in India in 2017, which is projected to rise to 134.3 million by the year 2045

Further the guidelines define the “Asian Indian phenotype” referring to a peculiar constellation of abnormalities in south Asians, whereby for any given level of body-mass index, they tend to have higher total body fat, visceral fat, insulin resistance and prevalence of diabetes compared to white Caucasians

Image Source: ICMR draft guidelines on Management of Type 2 diabetes 2018

The guidelines defining the various types of diabetes, specify the prevention screening, diagnosis criteria as well as containing pointers on the management,  both pharmacological and non-pharmacological treatment as well as diet in the disease. Further elaborating on the complications on the disease, it also touches co-morbid conditions including Hypertension, Obesity, Dyslipidemia as well as TB. The guidelines separately touch diabetes in pregnancy as well as childhood and adolescence

Some of the important pointers are enumerated below

Diagnostic Criteria for Diabetes

  •   Symptoms of diabetes (see box) plus casual or random plasma glucose ≥ 200 mg/dl (Casual means without regard to time of last meal)
  •   Fasting plasma glucose ≥ 126 mg/dl
  •   2 hour post 75 g glucose ≥ 200 mg/dl (as part of OGTT)
  •   Glycated Haemoglobin ≥ 6.5%

Any one positive test should be confirmed with another test subsequently.

Targets for metabolic control in diabetes

Image Source: ICMR draft guidelines on Management of Type 2 diabetes 2018

For further details and management of the disease, attached is the PDF of the complete guidelines. If you have any recommendations kindly send your Suggestions/Comments to Dr. Tanvir Kaur, Scientist ‘F’ at doctanvirkaur@gmail.com   by 18th May 2018; 5pm (IST)

 

 


Source: self
1 comment(s) on ICMR Issues guidelines on Type 2 Diabetes, Invites Comments; Check out details

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
  1. user
    Gundu H. R. Rao May 14, 2018, 6:04 pm

    I am delighted to see a comprehenisve ICMR guidelines for the management of type-2 diabetes. Having said that, it is hard to understand how a clinician or a patient will go through hundreds of pages of a written guideline ( more like a text book). To be useful a guidline should have important guidance statements for the clinicians as well as for the \”at risk \” subjects. In the absecence of a general check up or a population based screening, it is very difficult to prevent or reduce the increase in the incidence of type-2 diabetes in countries like India and China (NCD Risk Group Report. LANCET). Just like in majority of the countries, the healthcare in India, is disease -centirc and not geared at prevention or reduction of this chronic epidemic. It is high time, India and China address the issues related to Prevention or Reductionn of Metabolic Diseases. Just consider the fetal origin of adult diseses. India has pioneered the work on this subject for half a century (including ICMR supported studies) at Missiion Hospital, Mysore and KEM, Pune. Yet, there is hardly any intervetions in place to prevent this preventable risk.
    Gundu H. R. Rao, Emeritus Professor, Lillehei Heart Institue, University of Minnesota
    gundurao9@gmail.com. May14th 2018